Left ventricular global longitudinal strain in patients with coronary microvascular dysfunction and preserved

Lior Zornitzki1,2, Yotam Barlev3, Sheizaf Gefen4,3

  • 1Division of Cardiology, Tel Aviv Sourasky Medical Center affiliated with Tel Aviv University School of Medicine, Tel Aviv, Israel. lior.zoz@gmail.com.

Kardiologia Polska
|January 13, 2026
PubMed

Insights

Reduced left ventricular global longitudinal strain (LVGLS) is associated with coronary microvascular dysfunction (CMD). This finding suggests LVGLS may serve as an early non-invasive marker for CMD in patients with preserved ejection function.

Area of Science:

  • Cardiology
  • Echocardiography
  • Myocardial function

Background:

  • Left ventricular global longitudinal strain (LVGLS) is a sensitive indicator of myocardial injury.
  • Reduced LVGLS correlates with adverse outcomes in various cardiovascular conditions.
  • Evidence linking LVGLS to coronary microvascular dysfunction (CMD) is limited.

Purpose of the Study:

  • To investigate whether LVGLS is diminished in patients diagnosed with CMD.
  • To explore the relationship between LVGLS and CMD severity.

Main Methods:

  • Inclusion of patients with preserved ejection fraction (>50%) undergoing invasive coronary microvascular function assessment.
  • Semi-automated speckle-tracking software used for LVGLS measurement.
  • Univariate and multivariable analyses to assess associations between LVGLS, echocardiographic parameters, and coronary microvascular function.

Main Results:

  • Of 93 patients, 49 (52.6%) exhibited CMD. Patients with CMD showed significantly lower LVGLS (15.0%) compared to those without CMD (17.9%).
  • A trend of decreasing LVGLS was observed from no CMD to functional CMD to structural CMD (P=0.001).
  • Reduced LVGLS (<17.5%) was independently associated with CMD (adjusted OR, 3.61; P=0.01).

Conclusions:

  • Patients with CMD and preserved ejection function demonstrate lower LVGLS compared to controls.
  • LVGLS is progressively reduced in structural CMD versus functional CMD.
  • LVGLS may represent an early, non-invasive biomarker for detecting CMD.
Abstract